Jeffrey W. Sherman - 01 Jan 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role: EVP and Chief Medical Officer
Signature: /s/ Patrick McIlvenny, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 01 Jan 2023
Net transactions value: -$1,105,795
Form type: 4
Filing time: 04 Jan 2023, 15:27:11 UTC
Previous filing: 29 Dec 2022
Next filing: 06 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HZNP	Ordinary Shares	Options Exercise		+21,772	+917%		24,147	01 Jan 2023	Direct	F1
transaction	HZNP	Ordinary Shares	Tax liability	$1,105,795	-9,717	-40%	$113.80	14,430	01 Jan 2023	Direct
holding	HZNP	Ordinary Shares						54,501	01 Jan 2023	See Footnote	F2
holding	HZNP	Ordinary Shares						84,430	01 Jan 2023	See Footnote	F3
holding	HZNP	Ordinary Shares						66,730	01 Jan 2023	by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HZNP	Performance Restricted Stock Units (PSUs)	Options Exercise	$0	-21,772	-100%	$0.000000^*	0	01 Jan 2023	Ordinary Shares	21,772		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each PSU represents a contingent right to receive one ordinary share of the Issuer.
F2	The shares are held in the Jeffrey W. Sherman Living Trust.
F3	The shares are held in the name of the Jeffrey W. Sherman 2020 Gift Trust, of which the reporting person's spouse is the Trustee.
F4	The ordinary shares subject to the PSUs vested on January 1, 2023.